Study to Determine the Effects of Nebivolol and Hydrochlorothiazide in African Americans With Hypertension
Completed · Not applicable
Conditions studied: Hypertension
In brief
The main purpose of this study is to evaluate the effects of Nebivolol and Hydrochlorothiazide on blood pressure in African Americans with high blood pressure.
Key facts
- Study ID
- NCT00999752
- Run by
- InVasc Therapeutics, Inc.
- People needed
- 40
- Starts
- 2009-10-01
- Expected to finish
- 2010-05-01
- Last updated by the study team
- 2011-05-05
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Known Hypertension by history
- Self-described African American
You may not qualify if…
- Uncontrolled Diabetes Mellitus (HbA1C>10)
- Known CAD, Cerebrovascular Disease, PVD or Renovascular Disease
- Liver disease
- Chronic Renal Disease
- Uncontrolled Hypertension (>199 systolic and/or >115)
Where it is running
- Atlanta Vascular Research Foundation — Tucker, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.